These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 29891559)

  • 21. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
    Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
    J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD.
    Rogers KA; Moreno SE; Smith LA; Husson H; Bukanov NO; Ledbetter SR; Budman Y; Lu Y; Wang B; Ibraghimov-Beskrovnaya O; Natoli TA
    Physiol Rep; 2016 Jun; 4(12):. PubMed ID: 27356569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SNX9 Inhibits Cell Proliferation and Cyst Development in Autosomal Dominant Polycystic Kidney Disease via Activation of the Hippo-YAP Signaling Pathway.
    Shen AW; Fu LL; Lin L; Sun B; Song DX; Wang WT; Wang YH; Yin PR; Yu SQ
    Front Cell Dev Biol; 2020; 8():811. PubMed ID: 32974348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scribble influences cyst formation in autosomal-dominant polycystic kidney disease by regulating Hippo signaling pathway.
    Xu D; Lv J; He L; Fu L; Hu R; Cao Y; Mei C
    FASEB J; 2018 Aug; 32(8):4394-4407. PubMed ID: 29529391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Hippo pathway mediates inhibition of vascular smooth muscle cell proliferation by cAMP.
    Kimura TE; Duggirala A; Smith MC; White S; Sala-Newby GB; Newby AC; Bond M
    J Mol Cell Cardiol; 2016 Jan; 90():1-10. PubMed ID: 26625714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
    Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
    Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.
    Chen J; You H; Li Y; Xu Y; He Q; Harris RC
    J Am Soc Nephrol; 2018 Sep; 29(9):2372-2385. PubMed ID: 30072422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.
    Edwards DN; Ngwa VM; Wang S; Shiuan E; Brantley-Sieders DM; Kim LC; Reynolds AB; Chen J
    Sci Signal; 2017 Dec; 10(508):. PubMed ID: 29208682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
    Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
    Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The BET Bromodomain Inhibitor JQ1 Suppresses Chondrosarcoma Cell Growth via Regulation of YAP/p21/c-Myc Signaling.
    Zhang HT; Gui T; Sang Y; Yang J; Li YH; Liang GH; Li T; He QY; Zha ZG
    J Cell Biochem; 2017 Aug; 118(8):2182-2192. PubMed ID: 28059436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S1P/S1PR3 axis promotes aerobic glycolysis by YAP/c-MYC/PGAM1 axis in osteosarcoma.
    Shen Y; Zhao S; Wang S; Pan X; Zhang Y; Xu J; Jiang Y; Li H; Zhang Q; Gao J; Yang Q; Zhou Y; Jiang S; Yang H; Zhang Z; Zhang R; Li J; Zhou D
    EBioMedicine; 2019 Feb; 40():210-223. PubMed ID: 30587459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
    Lin C; Yao E; Chuang PT
    Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer.
    Zhang F; Sahu V; Peng K; Wang Y; Li T; Bala P; Aitymbayev D; Sahgal P; Schaefer A; Der CJ; Ryeom S; Yoon S; Sethi N; Bass AJ; Zhang H
    Gut; 2024 Jul; 73(8):1280-1291. PubMed ID: 38621923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of p114-RhoGEF and Lfc in Wnt-3a- and dishevelled-induced RhoA activation and neurite retraction in N1E-115 mouse neuroblastoma cells.
    Tsuji T; Ohta Y; Kanno Y; Hirose K; Ohashi K; Mizuno K
    Mol Biol Cell; 2010 Oct; 21(20):3590-600. PubMed ID: 20810787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
    Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
    J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YAP Activation in Renal Proximal Tubule Cells Drives Diabetic Renal Interstitial Fibrogenesis.
    Chen J; Wang X; He Q; Bulus N; Fogo AB; Zhang MZ; Harris RC
    Diabetes; 2020 Nov; 69(11):2446-2457. PubMed ID: 32843569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study of sirolimus and mTOR kinase inhibitor in a hypomorphic
    Holditch SJ; Brown CN; Atwood DJ; Lombardi AM; Nguyen KN; Toll HW; Hopp K; Edelstein CL
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F187-F196. PubMed ID: 31042058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic control of YAP and TAZ by the mevalonate pathway.
    Sorrentino G; Ruggeri N; Specchia V; Cordenonsi M; Mano M; Dupont S; Manfrin A; Ingallina E; Sommaggio R; Piazza S; Rosato A; Piccolo S; Del Sal G
    Nat Cell Biol; 2014 Apr; 16(4):357-66. PubMed ID: 24658687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
    Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
    J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.
    Park S; Kim J; Yang S; Kang SH; Kang W; Paik YH
    Mol Biol Rep; 2024 Sep; 51(1):950. PubMed ID: 39222158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.